Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials

por Locatelli, Francesco, Choukroun, Gabriel, Truman, Matt, Wiggenhauser, Alfons, Fliser, Danilo
Publicado 2016

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome

por Dall'Era, Maria, Levesque, Victoria, Solomons, Neil, Truman, Matt, Wofsy, David
Publicado 2015

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

por McDonald, Stephen, Yiu, Sean, Su, Li, Gordon, Caroline, Truman, Matt, Lisk, Laura, Solomons, Neil, Bruce, Ian N
Publicado 2022